Page 91 - UCT2012 Health Sciences

Basic HTML Version

Health Sciences
replacement, presenting with retroperitoneal hematoma
and successfully managed by percutaneous embolization
and coiling. Catheterization and Cardiovascular
Interventions, 80: 1002-1006.
Sinxadi, P., McIlleron, H., Dave, J.A., Smith, P.J., Levitt,
N. and Maartens, G. 2012. Association of lopinavir
concentrations with plasma lipid or glucose concentrations
in HIV-infected South Africans: a cross sectional study. AIDS
research and therapy, 9(32): 1-6.
Skelton, M., Kew, M.C. and Kramvis, A. 2012. Distinct
mutant hepatitis B virus genomes, with alterations in
all four open reading frames, in a single South African
hepatocellular carcinoma patient. Virus Research, 163(1):
Skolimowska, K., Rangaka, M.X., Meintjes, G., Pepper, D.J.,
Seldon, R.R., Matthews, K., Wilkinson, R.J. and Wilkinson,
K. 2012. Altered Ratio of IFN-y/IL-10 in patients with drug
resistant mycobacterium tuberculosis and HIV-tuberculosis
immune reconstitution inflammatory syndrome. PLoS One,
7(10): e46481.
Sliwa, K. and Zilla, P. 2012. Rheumatic heart disease: the tip
of the iceberg. Circulation, 125: 3060-3062.
Sliwa, K., Carrington, M., Becker, A., Thienemann, F.,
Ntsekhe, M. and Stewart, S. 2012. Contribution of the
human immunodeficiency virus/acquired immunodeficiency
syndrome epidemic to de novo presentations of heart
disease in the heart of Soweto study cohort. European
Heart Journal, 33: 866-874.
Sliwa, K., Lyons, J.G., Carrington, M., Lecour, S., Marais,
A.D., Raal, D. and Stewart, S. 2012. Different lipid profiles
according to ethnicity in the heart of Soweto study cohort
of de novo presentations of heart disease. Cardiovascular
Journal of Africa, 23(7): 389-395.
Smith, D., Bryer, A., Watson, L. and Greenberg, J. 2012.
Inherited polyglutamine spinocerebellar ataxias in South
Africa. SAMJ South African Medical Journal, 102(8): 683-
Smith, W.P. 2012. Triage in mass casualty situations. CME-
Continuing Medical Education, 30(11): 413-415.
Smythe, W., Khandelwal, A., Merle, C., Rustomjee, r.,
Gninafon, M., Bocar Lo, M., Sow, O.B., Olliaro, P., Lienhardt,
C., Horton, J., Smith, P.J., McIlleron, H. and Simonsson, U.
2012. A semimechanistic pharmacokinetic-enzyme turnover
model for rifampin autoinduction in adult tuberculosis
patients. Antimicrobial Agents and Chemotherapy, 56(4):
Somers, S., Frias, M., Lacerda, L., Opie, L.H. and Lecour,
S. 2012. Interplay between safe and risk pathways in
sphingosine-1-phosphate-induced cardioprotection.
Cardiovascular Drugs and Therapy, 26: 227-237.
Stanley, A., Candy, S., Levin, C. and Heckmann, J.M. 2012.
The complexity of HIV vasculopathy. SAMJ South African
Medical Journal, 102(6): 474-476.
Stewart, S., Carrington, M., Pretorius, S., Okechukwu, O.S.,
Blauwet, L., Antras-Ferry, J. and Sliwa, K. 2012. Elevated risk
factors but low burden of heart disease in urban African
primary care patients: a fundamental role for primary
prevention. International Journal of Cardiology, 158: 205-
Stinson, K., Boulle, A.M., Smith, P.J., Stringer, E.M., Stringer,
J.S.A. and Coetzee, D.J. 2012. Coverage of the prevention
of mother-to-child transmission program in the Western
Cape, South Africa using cord blood surveillance. Jaids-
Journal of Acquired Immune Deficiency Syndromes, 60(2):
Streicher, E.M., Bergval, I., Dheda, K., Bottger, E.C., Gey van
Pittius, N.C., Bosman, M., Coetzee, G., Anthony, R.M., Van
Helden, P., Victor, T. and Warren, R.M. 2012. Mycobacterium
tuberculosis population structure determines the outcome
of genetic - based second - line drug resistance testing.
Antimicrobial Agents and Chemotherapy, 56(5): 2420-2427.
Stuart-Clark, H., Vorajee, N., Zuma, S., van Niekerk, L.,
Burch, V.C., Raubenheimer, P.J. and Peter, J. 2012. Twelve-
month outcomes of patients admitted to the acute general
medical service at Groote Schuur Hospital. SAMJ South
African Medical Journal, 102(6): 549-553.
Sunpath, H., Edwin, C., Chelin, N., Nadesan, S., Maharaj,
R., Moosa, M.-Y.S., Smeaton, L., Court, R.G., Knight,
S.E., Gwyther, E. and Murphy, R. 2012. Operationalizing
early antiretroviral therapy in HIV-infected in-patients
with opportunistic infections including tuberculosis.
International Journal of Tuberculosis and Lung Disease,
16(7): 917-923.
Suthar, A.B., Lawn, S.D., del Amo, J., getahun, H., Dye,
C., Sculier, D., Sterling, T.R., Chaisson, R., Williams, B.,
Harries, A.D. and Granich, R. 2012. Antiretroviral therapy for
prevention of tuberculosis in adults with HIV: a systematic
review and meta-analysis. PLoS One, 9(7): e1001270.
Svensson, E., Van der Walt, J.-S., Barnes, K.I., Cohen, K.,
Kredo, T., Huitema, A., Nachega, J.B., Karlsson, M.O. and
Denti, P. 2012. Integration of data from multiple sources
for simultaneous modelling analysis: experience from
nevirapine population pharmacokinetics. British Journal of
Pharmacology, 74(3): 465-476.